Health Canada

All the posts published.

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019

Market Access News, Publications

Posted by MORSE Team

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018

Market Access News

Posted by MORSE Team

Has RWE in Canada Reached a Tipping Point?

October 23, 2018

Market Access News

Posted by Lorraine Boyle

Summary of the HC-HTA Alignment Webinar Sept. 2018

October 17, 2018

Market Access News

Posted by MORSE Team

Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources

September 26, 2017

Market Access News, What's New

Posted by MORSE Team

Introducing the MORSE WIRE – Live market access news and trends at your finger tips

June 22, 2017

Market Access News, What's New

Posted by MORSE Team

Federal Health Minister, Hon. Jane Philpott, Announces PMPRB Consultations

May 16, 2017

Market Access News

Posted by MORSE Team

Health Canada Guidance Document on the Disclosure of Confidential Business Information – March 10, 2017

March 10, 2017

Market Access News

Posted by MORSE Team

Terms of Reference for Scientific Advisory Panel on Opioid Use and Contraindications

February 28, 2017

Market Access News

Posted by MORSE Team

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.

Health Canada - Info and details on - MORSE Consulting Inc.

Health Canada

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

Significant Developments in Canadian Drugs for Rare Disease Policy

Has RWE in Canada Reached a Tipping Point?

Summary of the HC-HTA Alignment Webinar Sept. 2018

Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources

Introducing the MORSE WIRE – Live market access news and trends at your finger tips

Federal Health Minister, Hon. Jane Philpott, Announces PMPRB Consultations

Health Canada Guidance Document on the Disclosure of Confidential Business Information – March 10, 2017

Terms of Reference for Scientific Advisory Panel on Opioid Use and Contraindications

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers

HTA

pCPA

Public Payers

Health Canada

Patients

Private Payers